Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, NSW 2010, Australia; CIRCA (Clinical Immunogenomics Research Consortium of Australasia), Australia.
Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, NSW 2010, Australia; CIRCA (Clinical Immunogenomics Research Consortium of Australasia), Australia.
Curr Opin Immunol. 2023 Apr;81:102286. doi: 10.1016/j.coi.2023.102286. Epub 2023 Feb 8.
B cells are fundamental to host defence against infectious diseases; indeed, the ability of humans to elicit robust antibody responses following exposure to foreign antigens underpins long-lived humoral immunity and serological memory, as well as the success of most currently administered vaccines. However, B cells also have a dark side - they can cause myriad diseases, including autoimmunity, atopy, allergy and malignancy. Thus, it is critical to understand the molecular requirements for generating effective, high-affinity, specific immune responses following natural infection or vaccination, as well as for constraining B-cell function to mitigate B-cell-mediated immune dyscrasias. In this review, we discuss recent developments that have been derived from the identification and detailed analysis of individuals with inborn errors of immunity that disrupt cytokine signalling, resulting in immune dysregulatory conditions. These studies have defined fundamental cytokine/cytokine receptor/signal transducer and activator of transcription (STAT) signalling pathways that are critical for the generation and maintenance of human memory B-cell and plasma cell subsets during host defence, as well as revealed mechanisms of disease pathogenesis causing immune deficiency, autoimmunity and atopy. More importantly, these studies have identified molecules that could be targeted to either enhance humoral immunity in the settings of infection or vaccination, or attenuate humoral immunity that contributes to antibody-mediated autoimmunity or allergy.
B 细胞是宿主抵御传染病的基础;事实上,人类在接触外来抗原后能够产生强烈的抗体反应,这为长期的体液免疫和血清记忆以及大多数目前使用的疫苗的成功奠定了基础。然而,B 细胞也有阴暗面——它们可以导致许多疾病,包括自身免疫、过敏、过敏和恶性肿瘤。因此,了解在自然感染或接种疫苗后产生有效、高亲和力、特异性免疫反应的分子要求,以及限制 B 细胞功能以减轻 B 细胞介导的免疫功能紊乱,是至关重要的。在这篇综述中,我们讨论了最近的一些研究进展,这些进展来自于对先天免疫缺陷个体的鉴定和详细分析,这些缺陷会破坏细胞因子信号转导,导致免疫调节紊乱。这些研究定义了基本的细胞因子/细胞因子受体/信号转导和转录激活因子(STAT)信号通路,这些通路对于宿主防御过程中人类记忆 B 细胞和浆细胞亚群的产生和维持至关重要,并揭示了导致免疫缺陷、自身免疫和过敏的疾病发病机制的机制。更重要的是,这些研究已经确定了一些可以靶向的分子,这些分子可以在感染或接种疫苗的情况下增强体液免疫,或者减弱导致抗体介导的自身免疫或过敏的体液免疫。